Supportive cryotherapy: a review from head to toe.

[1]  J. Coebergh,et al.  Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer. , 2013, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[2]  Shukan Kanuga,et al.  Cryotherapy and keratinocyte growth factor may be beneficial in preventing oral mucositis in patients with cancer, and sucralfate is effective in reducing its severity. , 2013, Journal of the American Dental Association.

[3]  O. Erol,et al.  A comparison of men and women's experiences of chemotherapy-induced alopecia. , 2013, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[4]  Dora S P Lang.  Interventions for preventing oral mucositis for patients with cancer receiving treatment. , 2013, Clinical journal of oncology nursing.

[5]  D. Betticher,et al.  Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment , 2013, Supportive Care in Cancer.

[6]  K. Ohrn,et al.  Five-year follow-up of survival and relapse in patients who received cryotherapy during high-dose chemotherapy for stem cell transplantation shows no safety concerns. , 2012, European journal of cancer care.

[7]  J. Lemieux.  Reducing chemotherapy-induced alopecia with scalp cooling. , 2012, Clinical advances in hematology & oncology : H&O.

[8]  Philippe Bédard,et al.  Ocular toxicity of targeted therapies. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  A. Sevinç,et al.  Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy - a randomized controlled trial. , 2012, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[10]  G. Can,et al.  Taxane-induced nail changes: Predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity. , 2012, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[11]  S. Lauzier,et al.  Prospective cohort study of chemotherapy-induced alopecia with or without scalp cooling. , 2012 .

[12]  J. Nortier,et al.  Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia , 2012, Supportive Care in Cancer.

[13]  G. Birgegard,et al.  The effect of cryotherapy on oral mucosa: a study in healthy volunteers , 2012, Medical Oncology.

[14]  J. Jimenez,et al.  A novel rat model for chemotherapy‐induced alopecia , 2012, Clinical and experimental dermatology.

[15]  Lonneke V. van de Poll-Franse,et al.  Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - Results of the Dutch Scalp Cooling Registry , 2012, Acta oncologica.

[16]  Y. Bang,et al.  Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapy , 2012, Supportive Care in Cancer.

[17]  M. Fukushima,et al.  Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients , 2011, Supportive Care in Cancer.

[18]  R. S. Sarvestani,et al.  Efficacy of penguin cap as scalp cooling system for prevention of alopecia in patients undergoing chemotherapy. , 2011, Journal of advanced nursing.

[19]  G. Fraboulet,et al.  Frostbite as a complication of frozen gloves in the prevention of docetaxel-induced onycholysis. , 2011, European journal of dermatology : EJD.

[20]  V. Roy,et al.  Implementation of a standardized protocol for prevention and management of oral mucositis in patients undergoing hematopoietic cell transplantation , 2010, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[21]  E. Blanchard,et al.  Permanent chemotherapy-induced alopecia: case report and review of the literature. , 2010, Journal of the American Academy of Dermatology.

[22]  K. Ohrn,et al.  Oral cryotherapy reduces mucositis and improves nutrition - a randomised controlled trial. , 2010, Journal of clinical nursing.

[23]  Stefan Meyer,et al.  Interventions for treating oral mucositis for patients with cancer receiving treatment. , 2010, The Cochrane database of systematic reviews.

[24]  M. Naghizadeh,et al.  Allopurinol mouth rinse for prophylaxis of fluorouracil-induced mucositis. , 2010, European journal of cancer care.

[25]  P. Auvinen,et al.  The Effectiveness of a Scalp Cooling Cap in Preventing Chemotherapy-Induced Alopecia , 2010, Tumori.

[26]  H. Iwata,et al.  Phase II Clinical Study of Protection of Nail Change and Skin Toxicity by Using a Frozen Glove in Japanese Patients with Early Breast Cancer Treated by Docetaxel and Cyclophosphamide (TC) [TBCRG-03 Study]. , 2009 .

[27]  A. Vingerhoets,et al.  Impact of alopecia and scalp cooling on the well‐being of breast cancer patients , 2009, Psycho-oncology.

[28]  R. Hazin,et al.  Ocular complications of cancer therapy: a primer for the ophthalmologist treating cancer patients , 2009, Current opinion in ophthalmology.

[29]  R. Hogan.  Implementation of an Oral Care Protocol and Its Effects on Oral Mucositis , 2009, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.

[30]  R. Trüeb.  Chemotherapy-induced alopecia. , 2009, Seminars in cutaneous medicine and surgery.

[31]  E. Maunsell,et al.  Incidence of scalp metastases in breast cancer: a retrospective cohort study in women who were offered scalp cooling , 2009, Breast Cancer Research and Treatment.

[32]  A. Vingerhoets,et al.  Scalp cooling to prevent chemotherapy-induced hair loss: practical and clinical considerations , 2009, Supportive Care in Cancer.

[33]  M. Ishitobi,et al.  Multicenter phase II study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity for the breast cancer patients (Kinki Multidisciplinary Breast Oncology Group: KMBOG-0605). , 2009 .

[34]  M. Jefford,et al.  Nonpharmacologic strategies for managing common chemotherapy adverse effects: a systematic review. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  S. Ziebland,et al.  Have men been overlooked? A comparison of young men and women's experiences of chemotherapy‐induced alopecia , 2008, Psycho-oncology.

[36]  Louise Provencher,et al.  Chemotherapy‐induced alopecia and effects on quality of life among women with breast cancer: a literature review , 2008, Psycho-oncology.

[37]  J. Sørensen,et al.  Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies , 2008, Cancer.

[38]  A. Vingerhoets,et al.  The impact of cancer and chemotherapy: perceptual similarities and differences between cancer patients, nurses and physicians. , 2008, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[39]  S. Oudard,et al.  Matched case‐control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel‐induced onycholysis and cutaneous toxicity of the foot , 2008, Cancer.

[40]  C. Bouten,et al.  Effects of temperature and doxorubicin exposure on keratinocyte damage in vitro , 2008, In Vitro Cellular & Developmental Biology - Animal.

[41]  S. Sonis.  Pathobiology of oral mucositis: novel insights and opportunities. , 2007, The journal of supportive oncology.

[42]  J. Moreb,et al.  Six cases of permanent alopecia after various conditioning regimens commonly used in hematopoietic stem cell transplantation , 2007, Bone Marrow Transplantation.

[43]  R. Pieters,et al.  Protection against chemotherapy induced mucositis by TGF‐β2 in childhood cancer patients: Results from a randomized cross‐over study , 2007, Pediatric blood & cancer.

[44]  G. Oster,et al.  Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies , 2007, Supportive Care in Cancer.

[45]  G. Birgegard,et al.  Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy—a randomized controlled trial , 2007, Supportive Care in Cancer.

[46]  D. McGuire,et al.  Clinical Practice Guidelines for the Prevention and Treatment of Mucositis , 2007 .

[47]  M. Baccarani,et al.  Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group , 2007, Bone Marrow Transplantation.

[48]  C. Kalofonos,et al.  Prevention of 5-fluorouracil-related stomatitis by oral cryotherapy: a randomized controlled study. , 2007, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[49]  D. Maloney,et al.  A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation , 2006, Bone Marrow Transplantation.

[50]  D. McGuire,et al.  The role of basic oral care and good clinical practice principles in the management of oral mucositis , 2006, Supportive Care in Cancer.

[51]  C. Christodoulou,et al.  Scalp metastases and scalp cooling for chemotherapy-induced alopecia prevention. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[52]  A. Sevinç,et al.  Prevention of oral mucositis due to 5-fluorouracil treatment with oral cryotherapy. , 2005, Journal of the National Medical Association.

[53]  M. Peyromaure,et al.  Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  T. Shaw,et al.  Comparison of plain ice and flavoured ice for preventing oral mucositis associated with the use of 5 fluorouracil. , 2005, Journal of clinical nursing.

[55]  Şerife Karagözoğlu,et al.  Chemotherapy: the effect of oral cryotherapy on the development of mucositis. , 2005, Journal of clinical nursing.

[56]  W. Breed,et al.  Prevention of chemotherapy-induced hair loss by scalp cooling. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[57]  Y. Ikeda,et al.  Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients , 2005, Supportive Care in Cancer.

[58]  T. Shea,et al.  Palifermin for oral mucositis after intensive therapy for hematologic cancers , 2017 .

[59]  Sophia Rosman,et al.  Cancer and stigma: experience of patients with chemotherapy-induced alopecia. , 2004, Patient education and counseling.

[60]  Kiyohito Yoshida,et al.  Prophylactic efficacy of allopurinol ice ball for leucovorin/5-fluorouracil therapy-induced stomatitis. , 2004, Anticancer research.

[61]  M. Marangolo,et al.  Onycholysis secondary to multiple paclitaxel 1-hour infusions: possible role for its vehicle (Cremophor EL). , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[62]  Scott B Cantor,et al.  The burdens of cancer therapy , 2003, Cancer.

[63]  V. Botchkarev.  Molecular mechanisms of chemotherapy-induced hair loss. , 2003, The journal of investigative dermatology. Symposium proceedings.

[64]  C. Macduff,et al.  The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel. , 2003, European journal of cancer care.

[65]  J. Flanagan,et al.  Ocular Surface, Ocular Adnexal, and Lacrimal Complications Associated With the Use of Systemic 5-Fluorouracil , 2003, Ophthalmic plastic and reconstructive surgery.

[66]  B. Piraccini,et al.  Taxane-induced nail changes: incidence, clinical presentation and outcome. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[67]  A. Howard,et al.  Docetaxel‐induced nail dystrophy , 2002, The Australasian journal of dermatology.

[68]  P. Viens,et al.  Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy , 2002, Supportive Care in Cancer.

[69]  G. Wasner,et al.  Docetaxel-induced Nail Changes – A Neurogenic Mechanism: A Case Report , 2002, Journal of Neuro-Oncology.

[70]  S. Forsberg.  Scalp Cooling therapy and cytotoxic treatment , 2001, The Lancet.

[71]  R. V. van Oers,et al.  Effect of locally applied GM-CSF on oral mucositis after stem cell transplantation: a prospective placebo-controlled double-blind study , 2001, Annals of Hematology.

[72]  H. Mitchell,et al.  Evaluating the efficacy of scalp cooling using the Penguin cold cap system to reduce alopecia in patients undergoing chemotherapy for breast cancer. , 2000, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[73]  N. Pavlidis,et al.  Prevention of chemotherapy-induced alopecia using an effective scalp cooling system. , 2000, European journal of cancer.

[74]  C. Dunton,et al.  Onycholysis Associated with Weekly Administration of Paclitaxel , 1999, The Annals of pharmacotherapy.

[75]  S. Lipsitz,et al.  A phase II study of 5‐fluorouracil, leucovorin, and interferon‐α in the treatment of patients with metastatic or recurrent gastric carcinoma , 1999, Cancer.

[76]  S. Balcerzak,et al.  Phase II trial of edatrexate in relapsed or refractory germ cell tumors: A Southwest Oncology Group study (SWOG 9124) , 1998, Investigational New Drugs.

[77]  S. Sonis,et al.  The impact of mucositis on α‐hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies , 1998, Cancer.

[78]  J. Kirkwood,et al.  A phase II trial of edatrexate in patients with advanced renal cell carcinoma. An Eastern Cooperative Oncology Group study. , 1997, American journal of clinical oncology.

[79]  M. Inbar,et al.  Scalp cooling in the prevention of alopecia in patients receiving depilating chemotherapy , 1997, Supportive Care in Cancer.

[80]  P. Novotny,et al.  Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[81]  R. Mannel,et al.  A phase II trial of edatrexate in previously treated squamous cell cervical cancer: a Gynecologic Oncology Group study. , 1997, American journal of clinical oncology.

[82]  F. Mandelli,et al.  Ice pops to prevent melphalan-induced stomatitis , 1996, The Lancet.

[83]  A. Dueñas-González,et al.  Misoprostol prophylaxis for high-dose chemotherapy-induced mucositis: a randomized double-blind study. , 1996, Bone marrow transplantation.

[84]  G. Salles,et al.  Prevention of high dose L-PAM-induced mucositis by cryotherapy. , 1994, Bone marrow transplantation.

[85]  J. O'fallon,et al.  Inhibition of 5 ‐ fluorouracil‐induced ocular irritation by ocular ice packs , 1994, Cancer.

[86]  S. Cascinu,et al.  Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitis. , 1994, European journal of cancer. Part B, Oral oncology.

[87]  S. Eichmüller,et al.  Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone. , 1994, The American journal of pathology.

[88]  C. Loprinzi,et al.  A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5‐fluorouracil‐related stomatitis , 1993, Cancer.

[89]  S. Closs,et al.  Knowledge, expectations and experiences of patients receiving chemotherapy for breast cancer. , 1992, Scandinavian journal of caring sciences.

[90]  T. Therneau,et al.  Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[91]  S. Kenny,et al.  Effect of two oral care protocols on the incidence of stomatitis in hematology patients , 1990, Cancer nursing.

[92]  J. Jimenez,et al.  Protection from chemotherapy-induced alopecia in a rat model. , 1990, Science.

[93]  T. Therneau,et al.  A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5‐fluorouracil‐induced stomatitis , 1990, Cancer.

[94]  H. Lazarus,et al.  Ocular complications of systemic cancer chemotherapy. , 1989, Survey of ophthalmology.

[95]  F. Giulio,et al.  Scalp hypothermia in the prevention of doxorubicin‐induced hair loss , 1988, Cancer nursing.

[96]  R. Parker.  The effectiveness of scalp hypothermia in preventing cyclophosphamide-induced alopecia. , 1987, Oncology nursing forum.

[97]  K. O. Baxley,et al.  Alopecia: Effect on cancer patients' body image , 1984, Cancer nursing.

[98]  S. Zimm,et al.  The use of scalp hypothermia in the prevention of doxorubicin‐induced hair loss , 1984, Cancer.

[99]  S B Kaye,et al.  On the receiving end--patient perception of the side-effects of cancer chemotherapy. , 1983, European journal of cancer & clinical oncology.

[100]  R. P. Gregory,et al.  Prevention of doxorubicin-induced alopedia by scalp hypothermia: relation to degree of cooling. , 1982, British medical journal.

[101]  J. Doroshow,et al.  Ocular irritation from high‐dose methotrexate therapy: Pharmacokinetics of drug in the tear film , 1981, Cancer.

[102]  G. Witman,et al.  Misuse of scalp hypothermia. , 1981, Cancer treatment reports.

[103]  I. Smith,et al.  Prevention of doxorubicin-induced alopecia by scalp cooling in patients with advanced breast cancer. , 1981, British medical journal.

[104]  J. Dean,et al.  Prevention of doxorubicin-induced hair loss with scalp hypothermia. , 1979, The New England journal of medicine.

[105]  R. Smith,et al.  Fine needle aspiration cytology. , 1985, Journal of clinical pathology.

[106]  W. Louis,et al.  Ocular side effects with 5-fluorouracil. , 1979, Australian and New Zealand journal of medicine.

[107]  K. Macrae,et al.  DOXORUBICIN-INDUCED HAIR LOSS AND POSSIBLE MODIFICATION BY SCALP COOLING , 1977, The Lancet.

[108]  C. Loprinzi,et al.  Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy , 2012, Supportive Care in Cancer.

[109]  R. Yamazaki,et al.  Brief oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients , 2005, Supportive Care in Cancer.

[110]  L. Beex,et al.  Punctal and canalicular stenosis associated with systemic fluorouracil therapy , 2005, Documenta Ophthalmologica.

[111]  E. Perez,et al.  Phase I trial of edatrexate plus carboplatin in advanced solid tumors: amelioration of dose-limiting mucositis by ice chip cryotherapy , 2004, Investigational New Drugs.

[112]  J. Crowley,et al.  Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group study , 1997, Cancer Chemotherapy and Pharmacology.

[113]  C. Loprinzi,et al.  Cyclophosphamide, methotrexate, and 5-fluorouracil (CMF)-induced ocular toxicity. , 1990, Cancer investigation.

[114]  C. Presant,et al.  The effects of using Chemocap on occurrence of chemotherapy-induced alopecia. , 1983, Oncology nursing forum.

[115]  J. Dean,et al.  Scalp hypothermia: a comparison of ice packs and the Kold Kap in the prevention of doxorubicin-induced alopecia. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.